Scientific Discovery & AI, the science-to-patient journey: accelerants and obstacles from leaders across the field is a cross-sector intelligence report drawing on candid dialogue among 25 senior leaders from across the science-to-patient value chain: physicians, researchers, publishers, technologists, health system leaders and pharmaceutical manufacturers.

The report summarizes insights from The Summit — an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. It maps the findings from The Summit across four stages of the science-to-patient value chain: Discovery & Early Research, Clinical Development & Evidence Generation, Validation & Dissemination of clinical trial results and Real-World Application & Patient Impact.

Leaders gathered to discuss the question: “How do we responsibly apply the rapid growth of QI in all aspects of healthcare and life sciences to accelerate the translation of rigorous science into real-world patient impact? Read the report to understand the current challenges and opportunities identified by participants.